PHARMACEUTICAL
VETERAN MICHAEL WOKASCH JOINS OCULUS INNOVATIVE SCIENCES AS
CHIEF OPERATING OFFICER
PETALUMA, CA-- (July 11, 2006)—Oculus
Innovative Sciences, Inc., announced today that Michael Wokasch
has joined the company as chief operating officer. Mr. Wokasch
has more than twenty years of experience in the healthcare
industry, most recently as senior vice president of commercial
operations for the biopharmaceuticals division of Chiron
Corporation. He has held marketing and sales positions at
Merck & Co., Miles Pharmaceuticals (now Bayer), and Abbott
Laboratories; and senior management positions at Impax Laboratories,
Aurora BioSciences, and Gala Design. He received his bachelor
of science degree from the University of Minnesota, college
of pharmacy.
Mr. Wokasch will assume responsibility for
global operations including the company’s manufacturing
facilities in the United States, Mexico, and The Netherlands,
product development, and sales and marketing.
About Oculus
Oculus Innovative Sciences, Inc. is a medical technology
company focused on the development, manufacture and marketing
of a family of products intended to control infection in acute
and chronic wounds. The company's platform technology, called
Microcyn®, is a non-toxic, super-oxidized, water-based
solution that is designed to eliminate a wide range of bacteria,
viruses, fungi and spores.
Oculus’ principal operations are in
Petaluma, California, and it conducts business in Europe and
Latin America through its wholly owned subsidiaries, Oculus
Innovative Sciences Netherlands B.V. and Oculus Technologies
of Mexico, S.A. de C.V.
(Download
PDF: 96 KB) |
